Vidaza and Hypoglycemia - a phase IV clinical study of FDA data

Summary:

Hypoglycemia is reported as a side effect among people who take Vidaza (azacitidine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lantus, and have Magnesium metabolism disorder.

The phase IV clinical study analyzes which people have Hypoglycemia when taking Vidaza. It is created by eHealthMe based on reports of 12,799 people who have side effects when taking Vidaza from the FDA, and is updated regularly.

What is Vidaza?

Vidaza has active ingredients of azacitidine. It is often used in myelodysplastic syndrome. eHealthMe is studying from 12,837 Vidaza users. Check the latest studies of Vidaza.

What is Hypoglycemia?

Hypoglycemia (low blood sugar) is found to be associated with 1,703 drugs and 2,379 conditions by eHealthMe. Check the latest studies of Hypoglycemia.

On Aug, 06, 2026

12,799 people reported to have side effects when taking Vidaza.
Among them, 25 people (0.2%) have Hypoglycemia.

Among these 25 people:

How long have people been on Vidaza when they have Hypoglycemia? *

What is the gender of people who have Hypoglycemia when taking Vidaza? *

female: 18.18 %
male: 81.82 %

What is the age of people who have Hypoglycemia when taking Vidaza? *

What are other drugs people take besides Vidaza? *

What are other side effects people have besides Hypoglycemia? *

Fever: 11 people, 44.00%
Thrombocytopenia (decrease of platelets in blood): 11 people, 44.00%
Anaemia (lack of blood): 11 people, 44.00%
Fatigue (feeling of tiredness): 9 people, 36.00%
Dyspnea (difficult or laboured breathing): 9 people, 36.00%
Leukopenia (less number of white blood cells in blood): 9 people, 36.00%
Pneumonia: 8 people, 32.00%
Pulmonary Congestion (congestion in the lungs): 7 people, 28.00%
Acute Kidney Failure: 7 people, 28.00%
Acute Respiratory Failure: 7 people, 28.00%

What are the existing conditions these people have? *

Haemochromatosis (body to absorb more iron than usual from food): 7 people, 28.00%
Lymphoproliferative Disorder (a medical condition in which the immune system makes too many white blood cells): 7 people, 28.00%
Magnesium Metabolism Disorder (disease of magnesium utilization): 7 people, 28.00%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 24.00%
Metastatic Squamous Cell Carcinoma (cancer of squamous cells spreads to other part): 4 people, 16.00%
Constipation: 3 people, 12.00%
Type 2 Diabetes: 3 people, 12.00%
Pain: 3 people, 12.00%
Endophthalmitis (inflammation of the internal coats of the eye): 2 people, 8.00%
Chest Pain: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Vidaza and have Hypoglycemia?

- Check whether Hypoglycemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vidaza:

Vidaza (12,837 reports)

Hypoglycemia treatments and more:

Hypoglycemia (57,734 reports)

Browse all side effects of Vidaza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoglycemia:

Hypoglycemia (1,703 drugs)

Browse all the conditions that are associated with Hypoglycemia:

Hypoglycemia (2,379 conditions)

Related publications that referenced our studies

Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .
Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on azacitidine (the active ingredients of Vidaza) and Vidaza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.